Research Peptides
A high-purity research peptide studied in metabolism and mitochondrial research. Available in 10mg and 40mg, with every batch independently tested and dispatched from the UK.
A high-purity research peptide studied in metabolism and mitochondrial research. Available in 10mg and 40mg, with every batch independently tested and dispatched from the UK.
MOTS-C peptide UK is Crown Peptides' mitochondrial-derived 16-amino-acid peptide, available in 10mg and 40mg strengths for laboratory research.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region. Its discovery contributed to the concept that mitochondrial DNA can generate short bioactive peptides involved in communication between mitochondria and the rest of the cell.
MOTS-C research centres on mitochondrial signalling, metabolic stress adaptation, glucose utilisation, AMPK-related pathways and communication between mitochondria and the nucleus. In the landmark study that first identified the peptide, MOTS-c prevented diet-induced obesity and insulin resistance in mice through AMPK activation in skeletal muscle (Learn more). It also influences cellular energy metabolism [NAD+], making it an important tool in mitochondrial-derived peptide research.
Compound-level reference data. Batch-specific results appear on the Certificate of Analysis.
Work out concentration with the peptide calculatorCrown Peptides MOTS-C is supplied for controlled laboratory research with batch-specific analytical documentation. High-Performance Liquid Chromatography (HPLC) can assess chromatographic purity, while Mass Spectrometry provides molecular information used to support identity verification.
The batch-specific Certificate of Analysis is the definitive source for the exact purity result, identity data and analytical specification of the material supplied.
Researchers working with MOTS-C may also be interested in [NAD+], [SS-31], [Epitalon], [5-Amino-1MQ] and [L-Carnitine] — other compounds studied in cellular energy, metabolism and longevity-related research.
MOTS-C peptide UK from Crown Peptides is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region.
It is part of a class of mitochondrial-derived peptides that provide evidence for signalling communication between mitochondria and other cellular systems.
Research includes energy metabolism, glucose utilisation, metabolic stress responses and mitochondrial-to-nuclear signalling.
No. It is associated with a short open reading frame within mitochondrial DNA.
Peptide identity and purity can be evaluated with HPLC and Mass Spectrometry, with sequence and molecular data confirmed on the batch documentation.
Every batch is published openly — identity, purity and batch number, with no account needed.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.
Disclaimer: All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, consumption, therapeutic, or diagnostic application. By purchasing, you confirm you are a qualified professional and legally permitted to handle these materials in compliance with all applicable laws and regulations. Misuse, resale for unauthorised purposes, or unlawful application is strictly prohibited. Crown Peptides UK disclaims all liability for improper use, handling, or regulatory non-compliance.